Comparisons the MAC and RIC/NMA groups regarding engraftment and GVHD
| Variable . | MAC (n = 978) . | RIC/NMA (n = 777) . | P . |
|---|---|---|---|
| Neutrophil recovery, median (range), d | |||
| Time from transplant to engraftment | 14 (1-111) | 15 (<1-96) | .497 |
| Acute GVHD grades II-IV | |||
| Cumulative incidence (95% CI), % | 38 (35-41) | 31 (27-34) | .0011 |
| Time from transplantation to acute GVHD grades II-IV, median (range), d | 28 (7-176) | 33 (9-177) | <.001 |
| Chronic GVHD | |||
| Cumulative incidence (95% CI), % | 30 (27-33) | 23 (20-26) | .0018 |
| Time from transplantation to chronic GVHD, median (range), mo | 6 (2-72) | 6 (2-67) | .801 |
| Variable . | MAC (n = 978) . | RIC/NMA (n = 777) . | P . |
|---|---|---|---|
| Neutrophil recovery, median (range), d | |||
| Time from transplant to engraftment | 14 (1-111) | 15 (<1-96) | .497 |
| Acute GVHD grades II-IV | |||
| Cumulative incidence (95% CI), % | 38 (35-41) | 31 (27-34) | .0011 |
| Time from transplantation to acute GVHD grades II-IV, median (range), d | 28 (7-176) | 33 (9-177) | <.001 |
| Chronic GVHD | |||
| Cumulative incidence (95% CI), % | 30 (27-33) | 23 (20-26) | .0018 |
| Time from transplantation to chronic GVHD, median (range), mo | 6 (2-72) | 6 (2-67) | .801 |